Cytokines are immunoregulatory proteins involved in many pathological states with
promising potential as therapeutic agents. A diverse array of cytokines has been studied in …

Therapeutic macromolecules such as proteins are conventionally administered via bolus
injection, an approach that presents significant limitations. Sustained-release biodegradable …

Introduction: Combination therapy with pegylated interferon alpha (Peg-interferon) and
ribavirin is currently the cornerstone of antiviral therapy for chronic hepatitis C. Monotherapy …

The immunomodulatory, antiproliferative, and antiviral properties of interferons alpha (IFN-α)
have made these cytokines attractive for numerous clinical applications. However, most of …

Interferon-α (IFNα) has enormous potential for anti-proliferative and anti-viral treatments.
However, clinical success is still hampered due to its limited bioavailability and thus, lack of …

The natural history of chronic hepatitis C virus (HCV) infection is one of disease progression
with worsening liver fibrosis leading to the development of cirrhosis and related …

Using transgenic plants as factories for production of physiologically active human proteins
arouses special concern because occasional escape of such transgenes into environment …

Hepatitis C infection represents a major global public health problem; as it leads to
significant morbidity, mortality, and financial burden on healthcare system. According to …